Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling

Peng Zhu,Jianqiang Qian,Zhongyuan Xu,Chi Meng,Ji Liu,Wenpei Shan,Weizhong Zhu,Yongjun Wang,Yumin Yang,Wei Zhang,Yanan Zhang,Yong Ling

DOI: https://doi.org/10.1021/acs.jnatprod.0c00599

IF: 5.1

2020-10-07

Journal of Natural Products

Abstract:The natural products piperlongumine and piperine have been shown to inhibit cancer cell proliferation through elevation of reactive oxidative species (ROS) and eventually cell death, but only have modest cytotoxic potencies. A series of 14 novel phenylallylidenecyclohexenone analogues based on piperlongumine and piperine therefore were designed and synthesized, and their pharmacological properties were evaluated. Most of the compounds produced antiproliferative activities against five human cancer cells with IC₅₀ values lower than those of piperlongumine and piperine. Among these, compound <b>9m</b> exerted the most potent antiproliferative activity against drug-resistant Bel-7402/5-FU human liver cancer 5-FU resistant cells (IC₅₀ = 0.8 μM), which was approximately 10-fold lower than piperlongumine (IC₅₀ = 8.4 μM). Further, <b>9m</b> showed considerably lower cytotoxicity against LO2 human normal liver epithelial cells compared to Bel-7402/5-FU. Mechanistically, compound <b>9m</b> inhibited thioredoxin reductase (TrxR) activity, increased ROS levels, reduced mitochondrial transmembrane potential (MTP), and induced autophagy in Bel-7402/5-FU cells via regulation of autophagy-related proteins LC3, p62, and beclin-1. Finally, <b>9m</b> activated significantly the p38 signaling pathways and suppressed the Akt/mTOR signaling pathways. In conclusion, <b>9m</b> could be a promising candidate for the treatment of drug-resistant cancer cells and, as such, warrants further investigation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00599?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00599</a>.¹H NMR and ¹³C NMR spectra for compounds <b>9a</b>–<b>n</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00599/suppl_file/np0c00599_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

plant sciences,chemistry, medicinal,pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new natural product analogues with stronger anti - cancer activity. Specifically, the researchers designed and synthesized 14 new styryl cyclohexenone analogues. These analogues are based on the natural products piperlongumine and piperine, aiming to increase the cytotoxicity to cancer cells and pay special attention to the inhibitory effect on drug - resistant liver cancer cells. The main objectives of the study include:

1. **Increase cytotoxicity**: By designing and synthesizing new analogues, the researchers hope to find compounds that are more cytotoxic than the original compounds piperine and piperine, especially for a variety of human cancer cell lines, including drug - sensitive and drug - resistant cancer cells.

2. **Enhance TrxR inhibitory activity**: Piperine and piperine are known to induce an increase in the level of reactive oxygen species (ROS) in cancer cells by inhibiting thioredoxin reductase (TrxR), thereby leading to apoptosis. Therefore, the researchers hope to enhance this mechanism by designing new analogues to further improve the anti - cancer effect.

3. **Reduce metabolic instability**: The lactam ring in piperine is easily hydrolyzed, which may lead to metabolic instability. The lactam ring was removed in the design of new analogues to reduce the concern of metabolic instability.

4. **Simplify the synthesis route**: New analogues can be obtained by a one - step synthesis method, which greatly shortens the synthesis time and improves the synthesis efficiency.

The research results show that one of the compounds, 9m, shows significant improvements in multiple aspects. For example, its cytotoxicity to the drug - resistant liver cancer cell Bel - 7402/5 - FU is about 10 times stronger than that of piperine, while its cytotoxicity to the normal liver epithelial cell LO2 is relatively low. In addition, 9m can effectively inhibit TrxR activity, increase ROS levels, reduce mitochondrial membrane potential, induce autophagy, activate the p38 signaling pathway, and inhibit the Akt/mTOR signaling pathway. These results indicate that 9m is a potential drug candidate worthy of further study.